Biotech Growth Trust plc (The) (BIOG) Ordinary 25p
Sell:764.00p
Buy:772.00p
0
Change:
No change
No change
FTSE All Share:0.30%
Market closed |
Prices as at close on 25 March 2025
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- Create an alert
- This stock can be held in a
Sell:764.00p
Buy:772.00p
Change:
No change
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 25 March 2025
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:764.00p
Buy:772.00p
Change:
No change
No change
Market closed |
Prices as at close on 25 March 2025
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
n/a
n/a
Trade high:
n/a
n/a
Year high:
1,068.00p
1,068.00p
Estimated NAV:
864.16
864.16
Previous close:
768.00p
768.00p
Trade low:
n/a
n/a
Year low:
760.00p
760.00p
Premium/Discount:
-9.39%
-9.39%
Previous:
15.00p (1.92%) Previous:
15.00p
15.00p (1.92%) Previous:
15.00p
Volume:
n/a
n/a
Dividend yield:
n/a
n/a
Currency:
GBX
GBX
Data delayed by at least 15 minutes.
Price
-
Net Asset Value (NAV)
Performance
| 1 week 1W | 1.16% | 1 year 1Y | 21.55% |
|---|---|---|---|
| 1 month 1M | 6.23% | 2 years 2Y | 2.66% |
| 3 months 3M | 11.11% | 3 years 3Y | 12.93% |
| 6 months 6M | 23.51% | 5 years 5Y | 3.76% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
| Benchmark: | NASDAQ Biotechnology TR GBP |
|---|---|
| Annual management charge: | n/a |
| Performance fee: | Yes |
| Ongoing charge: | 1.20% |
| Dividend yield: | n/a |
| Dividend frequency: | None |
| Total assets: | £239m |
| Gross gearing: | 0% |
| Market capitalisation:Market cap.: | £217m |
| Shares in issue: | 27.69 million |
| Legal structure | Closed Ended Investment Company |
| Domicile: | United Kingdom |
| ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
The Company seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
NET ASSET VALUE (NAV)
| Estimated NAV: | 864.16p |
|---|---|
| Latest actual NAV: | 862.34p |
| Latest actual NAV date: | 24 March 2025 |
| Premium/Discount: | -9.39% |
| 12m average Premium/Discount: | -8.29% |
| NAV frequency: | Daily |
| Security | Weight |
|---|---|
| Neurocrine Biosciences Inc | 5.98% |
| Sarepta Therapeutics Inc | 5.87% |
| Alnylam Pharmaceuticals Inc | 4.97% |
| Ionis Pharmaceuticals Inc | 4.75% |
| Avidity Biosciences Inc Ordinary Shares | 4.18% |
| Dyne Therapeutics Inc Ordinary Shares | 3.91% |
| Intra-Cellular Therapies Inc | 3.33% |
| CG Oncology Inc | 3.31% |
| Vera Therapeutics Inc Class A | 3.30% |
| Xenon Pharmaceuticals Inc | 3.24% |
| Sector | Weight |
|---|---|
| Healthcare | 103.36% |
| Country | Weight |
|---|---|
| United States | 92.63% |
| China | 5.90% |
| Canada | 4.46% |
| Germany | 1.43% |
| Switzerland | 1.23% |
Key Dates
| Launch date: | 23 June 1997 |
|---|---|
| Financial year end: | March |
| Next AGM: | July 2025 |
Data policy -
All information should be used for indicative purposes only. You should independently
check data before making any investment decision. HL cannot guarantee that the data is
accurate or complete, and accepts no responsibility for how it may be used.
Prices provided by NBTrader. Charts provided by Factset.
Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics,
holding data, key dates, objective and NAV provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.